摘要
Background: The prognosis of human glioma is poor, and the highly invasive nature of the disease represents a major impediment to current therapeutic modalities. The oncoprotein B-cell-specific Moloney murine leukemia virus integration site 1 protein (Bmi-1) has been linked to the development and progression of glioma; however, the biological role of Bmi-1 in the invasion of glioma remains unclear. <br>Methods: A172 and LN229 glioma cells were engineered to overexpress Bmi-1 via stable transfection or to be silenced for Bmi-1 expression using RNA interfering method. Migration and invasiveness of the engineered cells were assessed using wound healing assay, Transwell migration assay, Transwell matrix penetration assay and 3-D spheroid invasion assay. MMP-9 expression and activity were measured using real-time PCR, ELISA and the gelatin zymography methods. Expression of NF-kappaB target genes was quantified using real-time PCR. NF-kappaB transcriptional activity was assessed using an NF-kappaB luciferase reporter system. Expression of Bmi-1 and MMP-9 in clinical specimens was analyzed using immunohistochemical assay. <br>Results: Ectopic overexpression of Bmi-1 dramatically increased, whereas knockdown of endogenous Bmi-1 reduced, the invasiveness and migration of glioma cells. NF-kappaB transcriptional activity and MMP-9 expression and activity were significantly increased in Bmi-1-overexpressing but reduced in Bmi-1-silenced cells. The reporter luciferase activity driven by MMP-9 promoter in Bmi-1-overexpressing cells was dependent on the presence of a functional NF-kappaB binding site, and blockade of NF-kappaB signaling inhibited the upregulation of MMP-9 in Bmi-1 overexpressing cells. Furthermore, expression of Bmi-1 correlated with NF-kappaB nuclear translocation as well as MMP-9 expression in clinical glioma samples. <br>Conclusions: Bmi-1 may play an important role in the development of aggressive phenotype of glioma via activating the NF-kappaB/MMP-9 pathway and therefore might represent a novel therapeutic target for glioma.
学科与关键词
- Bmi-1 Promotes Glioma Angiogenesis by Activating NF-kappa B SignalingJiang Lili; Song Libing; Wu Jueheng; Yang Yi; Zhu Xun; Hu Bo; Cheng Shi Yuan; Li Mengfeng*PLoS ONE, 2013, 8(1): e55527.被引 15
- Oncoprotein Bmi-1 Renders Apoptotic Resistance to Glioma Cells through Activation of the IKK-Nuclear Factor-kappa B PathwayLi Jun; Gong Li Yun; Song Li Bing; Jiang Li Li; Liu Li Ping; Wu Jueheng; Yuan Jie; Cai Jun Chao; He Mian; Wang Lan; Zeng Musheng; Cheng Shi Yuan; Li Mengfeng*AMERICAN JOURNAL OF PATHOLOGY, 2010, 176(2): 699-709.被引 46
- Knockdown of stomatin-like protein 2 (STOML2) reduces the invasive ability of glioma cells through inhibition of the NF-kappa B/MMP-9 pathwaySong Libing; Liu Liping; Wu Zhiqiang; Lin Chuyong; Dai Ting; Yu Chunping; Wang Xi; Wu Jueheng; Li Mengfeng; Li Jun*Journal of Pathology, 2012, 226(3): 534-543.被引 24
